Apoptosis pathways and neuroblastoma therapy.
1University Children's Hospital, Ulm, Germany. simone.fulda@uniklinik-ulm.de
Current Pharmaceutical Design
|February 10, 2009
Summary
Neuroblastoma cells evade apoptosis, a key cell death process, contributing to treatment resistance. Understanding apoptosis pathways is crucial for developing targeted neuroblastoma therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Research
Background:
- Evasion of apoptosis is a critical hallmark of human cancers, including neuroblastoma.
- The failure of tumor cells to undergo apoptosis often leads to resistance against conventional anticancer therapies like chemotherapy, radiation, and immunotherapy.
- Apoptosis induction is the primary mechanism by which most clinical anticancer treatments exert their cytotoxic effects.
Purpose of the Study:
- To investigate the molecular mechanisms governing apoptosis in neuroblastoma cells.
- To identify key signaling pathways and molecules involved in regulating programmed cell death in neuroblastoma.
- To provide a foundation for developing novel molecularly targeted therapies for neuroblastoma.
Main Methods:
- This study focuses on analyzing the molecular pathways controlling apoptosis in neuroblastoma.
- Methods likely involve molecular biology techniques, cell culture, and potentially preclinical models to study cell death signaling.
- Specific experimental details are not provided in the abstract but would typically include gene expression analysis, protein interaction studies, and functional assays.
Main Results:
- The abstract does not detail specific results but implies that understanding apoptosis regulation is key.
- Findings are expected to elucidate how neuroblastoma cells evade programmed cell death.
- The research aims to identify specific molecular targets within these pathways.
Conclusions:
- Understanding the regulation of apoptosis in neuroblastoma is essential for overcoming treatment resistance.
- Identifying novel molecular targets involved in apoptosis can pave the way for innovative therapeutic strategies.
- Targeted therapies aimed at restoring apoptosis in neuroblastoma cells hold promise for improving patient outcomes.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...